(Q46123241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Marcel Verbeek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Umesh Badrising

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Helma Pluk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Bas J A van Hoeve

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sander H J van Dooren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Judith Stammen-Vogelzangs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Annemarie van der Heijden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Helenius J Schelhaas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Snjolaug Arnardottir

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Karina Gheorghe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Wilbert C Boelens

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Baziel G van Engelen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Ger J M Pruijn

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

4 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

397-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23460448%20AND%20SRC:MED&resulttype=core&format=json

Inclusion body myositis: old and new concepts

25 February 2020

cites work

1 reference

Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies

21 January 2018

1 reference

Polymyositis and dermatomyositis

21 January 2018

1 reference

Immunotherapy of myositis: issues, concerns and future prospects

21 January 2018

1 reference

Developments in the scientific and clinical understanding of inflammatory myopathies

21 January 2018

1 reference

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis

21 January 2018

1 reference

Sporadic inclusion body myositis: a continuing puzzle

21 January 2018

1 reference

Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers

21 January 2018

1 reference

Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation

21 January 2018

1 reference

Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers

21 January 2018

1 reference

Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies

21 January 2018

1 reference

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition

21 January 2018

1 reference

Theories of the pathogenesis of inclusion body myositis

21 January 2018

1 reference

Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis

21 January 2018

1 reference

Inflammatory, immune, and viral aspects of inclusion-body myositis

21 January 2018

1 reference

A local antigen-driven humoral response is present in the inflammatory myopathies

21 January 2018

1 reference

Plasma cells in muscle in inclusion body myositis and polymyositis.

21 January 2018

1 reference

Molecular profiles of inflammatory myopathies.

21 January 2018

1 reference

High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.

21 January 2018

1 reference

Autoantibody profiles in the sera of European patients with myositis

21 January 2018

1 reference

Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.

21 January 2018

1 reference

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis

21 January 2018

1 reference

Increased plasma amyloid-beta42 protein in sporadic inclusion body myositis

21 January 2018

1 reference

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

21 January 2018

1 reference

Inflammatory muscle diseases: a critical review on pathogenesis and therapies

21 January 2018

1 reference